misryoum global news networkMar 2

GLP-1s may increase risk of osteoporosis and gout, new research finds

https://misryoum.com/us/us-news/glp-1s-may-increase-risk-of-osteoporosis-and/

GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ annual meeting.Dr. John Horneff, an associate professor of...

#GLP1s #may #increase #risk #osteoporosis #and #gout #new #research #finds #US_News_Hub #misryoum_com

GLP-1s may increase risk of osteoporosis and gout, new research finds

GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the

US News Hub
Hacker NewsJul 13, 2025

GLP-1s Are Breaking Life Insurance

https://www.glp1digest.com/p/how-glp-1s-are-breaking-life-insurance

#HackerNews #GLP1s #LifeInsurance #HealthTech #MedicalInnovation #InsuranceIndustry

How GLP-1s Are Breaking Life Insurance

Patients look healthy on paper. Two years later, they're high-risk again.

GLP-1 Digest
Steve Dustcircle 🌹Jun 22, 2025

#EliLilly’s #Obesity #Pill Appears to Work as Well as Injected #GLP1s

https://www.wired.com/story/lilly-obesity-pill-effective-orforglipron-injected-glp-1-ozempic/

Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.

WIRED
ConscienHealthOct 19, 2024
New research in the Addiction journal suggests that the rates of #drug and #AlcoholAbuse might be lower by as much as half when people are taking #GLP1s. Will these medicines become important tools for substance use disorders?
https://conscienhealth.org/2024/10/less-drug-and-alcohol-abuse-when-people-take-glp-1s/
Less Drug and Alcohol Abuse When People Take GLP-1s - ConscienHealth

New observational research suggests that rates of drug and alcohol abuse might be lower by as much as half when people are taking GLP-1s.

ConscienHealth
ConscienHealthSep 2, 2024
Delayed aging? Fountain of youth? Health reporting about #GLP1s moved into the range of #IrrationalExuberance over the weekend. Good news is worth celebrating, but let's stay tethered to reality.
https://conscienhealth.org/2024/09/rational-and-irrational-exuberance-about-glp-1-medicines/
Rational and Irrational Exuberance About GLP-1 Medicines - ConscienHealth

In the last few days, we’ve seen enthusiasm about good news tip into irrational exuberance about GLP-1 agonists. It’s not wise.

ConscienHealth
ConscienHealthAug 13, 2024
New signals suggest that #GLP1s might reduce the risk of obesity-related #cancer. Increasingly, it looks like obesity treatment is a pretty solid #prevention strategy for future health problems.
https://conscienhealth.org/2024/08/treating-obesity-as-a-risk-reduction-strategy-for-cancer/
Treating Obesity as a Risk Reduction Strategy for Cancer - ConscienHealth

Once again, a signal from surveillance of GLP-1 agonists suggests these drugs may offer a risk reduction strategy for cancer.

ConscienHealth
ConscienHealthAug 11, 2024
A new analysis of prescribing patterns for #GLP1s suggests that the demand is centered more in Kentucky than Hollywood.
Thx to @bloomberg for digging deeper than popular narratives.
https://conscienhealth.org/2024/08/the-demand-for-ozempic-more-waffle-house-than-whole-foods/
The Demand for Ozempic: More Waffle House Than Whole Foods - ConscienHealth

The narrative of booming demand for Ozempic in Hollywood can be misleading. The uptake may be greater in places like Bowling Green, KY.

ConscienHealth
ConscienHealthJul 29, 2024
When the subject of #EquitableAccess to #GLP1s arises, contrasting perspectives of what is equitable become apparent. The #LostPerspective is that these medicines are not going to communities with the greatest need.
https://conscienhealth.org/2024/07/trends-in-diabetes-obesity-and-equitable-access-to-glp-1s/
Trends in Diabetes, Obesity, and Equitable Access to GLP-1s - ConscienHealth

When the subject of equitable access to GLP-1s arises, contrasting perspectives of what is equitable become apparent.

ConscienHealth
ConscienHealthJul 26, 2024
Some people complain that #GLP1s distract from the #HealthLifestyles they want to sell. But what if it turns out that they make healthy lifestyles more achievable? #DiscomfortOfThought
https://conscienhealth.org/2024/07/will-glp-1s-level-the-field-in-an-obesogenic-environment/
Will GLP-1s Level the Field in an Obesogenic Environment? - ConscienHealth

Some think GLP-1s are a distraction from healthy lifestyles. But what if they serve to level the field in an obesogenic environment?

ConscienHealth
ConscienHealthJun 29, 2024
The realization that #GLP1s can improve lives by silencing #FoodNoise gives us pause to think. What are the #PublicHealth implications of silencing food noise?
https://conscienhealth.org/2024/06/food-noise-in-our-heads-and-all-around-us/
Food Noise – in Our Heads and All Around Us - ConscienHealth

Because new obesity medicines can quiet the food noise within us, does this have implications for the food cues all around us?

ConscienHealth